NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS

Clinical trials for NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.

Never miss a new study

Get alerted when new NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS trials appear

Sign up with your email to follow new studies for NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Experimental drug targets debilitating 'Brain Fog' in lupus patients

Disease control Completed

This study tested whether a drug called EG-501 could improve thinking and memory problems, often called 'brain fog,' in people with lupus. 131 adults with lupus and confirmed cognitive impairment were randomly assigned to receive either EG-501 or a placebo (inactive substance) fo…

Matched conditions: NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS

Phase: PHASE2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS

Get alerted when new NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS trials appear

Experimental drug targets debilitating 'Brain Fog' in lupus patients